Ajay Samkaria/LinkedIn
May 22, 2026, 13:36
Ajay Samkaria։ A Compatible Crossmatch Does Not Always Mean Complete Safety
Ajay Samkaria, Product and Application Manager India at Diagast, shared a post on LinkedIn:
“Crossmatch protects the present transfusion.
Antibody screening protects the patient’s future.
A compatible crossmatch does not always mean complete transfusion safety.
Some clinically significant antibodies may still go undetected unless proper antibody screening is performed.
That’s why modern transfusion medicine is shifting from: ‘minimum compatibility’ to ‘future transfusion safety.’
Think Beyond Crossmatch.
Think Antibody Screening.
Think Patient Safety.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease
-
Oct 9, 2026, 13:55Chandler Purser: AABB 2026 Focuses on Transfusion Safety and Audit-Driven Practice Improvement
-
Oct 9, 2026, 13:48Maxime Dely: Raising Awareness for Blood Donation
-
Oct 9, 2026, 13:48Vera Ghali: Anemia in Myelofibrosis and Its Impact on Treatment Outcomes and Overall Survival
-
Oct 9, 2026, 13:32W David Freeman։ The Mechanical Penumbra in Intracerebral Hemorrhage and Its Potential for Tissue Recovery
-
Oct 9, 2026, 13:11Ayshathul Noora։ Carbetocin vs Oxytocin in Preventing Postpartum Hemorrhage
-
Oct 9, 2026, 13:07The Rebalanced Patient: New Therapies and New Thrombotic Risks in Hemophilia
-
Oct 9, 2026, 12:48Santiago Cepeda Chafla: CereBleed Simplifies Brain Hemorrhage Assessment